Dr. A P J Abdul Kalam at the 43rd Annual General Meeting of OPPI.

Highlights of Dr. A P J Abdul Kalam comments on Innovative Packaging at the 43rd Annual General Meeting of OPPI.

Visit : http://www.bilcare.com/insight/dimensions_of_healthcare.htm

Empowering Consumers to make Safer Buying Decisions : nonClonableID Technologies

With breakthrough research and development in nanotechnology and an emphasis on creating a cost-effective solution, Bilcare has created a first-of-its-kind nonClonableID™ Authentication Technology. Bilcare Technologies is a comprehensive response to counterfeiting and an indispensable tool for building confidence in consumers. Find out how our unique technology provides an increased degree of security and empowers consumers to authenticate a product in real-time.

nonClonableID Technologies

Bilcare Technologies is a research and technology leader focused on creating next-generation anti-counterfeiting, security and brand protection solutions for a broad range of industry sectors.

Bilcare Technologies is a business unit of Bilcare Ltd. - an innovation-led solutions provider that partners with the global pharmaceutical and healthcare industry to improve patient healthcare outcomes.

With breakthrough research and development in micro and nanotechnology, Bilcare Technologies has developed a first-of-its-kind technology - nonClonableID™. The solution enables products to be authenticated as they move through the supply chain to the end consumer.

India, Bilcare Technologies combines its innovative approach with in-depth business knowledge in brand protection and supply chain integrity to offer solutions tailored to varying client requirements.

We are firmly committed to helping our clients accomplish their business goals while protecting their brands against counterfeiting. With its affordability, security and ease of use, nonClonableID™ is a potent tool for the global economy in its fight against counterfeiting.

About nonClonableID

Bilcare’s nonClonableID™ comprises of a unique fingerprint that can be seamlessly integrated with products, ID cards and documents to provide a totally secure and reliable identification and authentication solution.

nonClonableID™ employs unique materials-based fingerprints that are prohibitively difficult to copy. These tamper-evident fingerprints are irreproducible and cannot be duplicated even by Bilcare.

Features of nonClonableID™

• Unique fingerprints generated out of randomly distributed micro and nano particles
• Machine-readable fingerprints enable an objective and reliable authentication process
• Real-time authentication through hand-held portable readers
• Fingerprints can be integrated with overt systems like barcodes/ RFID tags etc. and within any existing software/hardware infrastructure
• Proprietary scanning device scans the fingerprint and instantly communicates the encrypted information with a secure server through mobility platforms such as GPRS, 3G or Broadband.
• Complete authentication report on a mobile or computer using robust web enterprise secured applications and data management at back-end.

Bilcare GCS Expands Pre-Clinical and Early-Stage Development Capabilities

PHOENIXVILLE, Pa — November, 2008 — In its endeavor to accelerate the development process cycle resulting in enhanced “Speed to Market” for its clients, Bilcare Global Clinical Supplies, a leading single-source provider of Clinical Trial Supplies and services, endorses its continual capability enhancement commitment by supplementing its ability of developing functionally viable and innovative formulation dosage forms for pre-clinical and early-phase drugs.

Vincent Santa Maria, President – Bilcare GCS, Americas stated that as part of a major capital investment program at its facilities in the U.S., Bilcare GCS has added sophisticated fluid bed granulation and enhanced capsule filling technologies to its R&D Center. “With this upgrade, Bilcare GCS can now quickly produce a wider variety of drug dosage forms with high product quality at par industry benchmark. These investments in R&D services further prove our commitment to being a full-service partner to our global customers with the offering of a wide breath of specialty services, continues Vincent.”

This capability enhancement compliments the increasing number of investigational new drug (IND) applications by innovator pharma and Biotech companies, which in turn requires multi-pronged expertise, more particularly in the Formulation and Analytical research and development, commented Praful Naik, Ph.D., Chief Scientific Officer, Bilcare Limited.

The fluid-bed granulation technology extends Bilcare’s solid dosage formulation capabilities. The granulation system equipped with Wurster coating inserts enables Bilcare to develop and deliver specialized coating processes for granules and non-pareils with high precision and consistency for creation of top quality sustained and controlled-release tablet and capsule formulations.

The In-Cap® capsule system, capable of filling several thousand capsules per hour in multiple permutations, is a versatile tool for pre-clinical and early-stage development. This equipment extends both development and clinical manufacturing capabilities for a myriad of formulation types including powders, pellets, tablets and liquids.

“Bilcare’s R&D center can now develop a broad array of dosage forms with innovative delivery mechanisms, which exceeds those developed by pharmaceutical companies,” says Frank Santillo, Ph.D., Bilcare GCS’ senior director for research services. “Most importantly, we have the expertise to take a drug candidate from concept to clinical production without the client suffering critical and costly delays as a result of hand-offs, continues Frank”

About Bilcare Global Clinical Supplies

Bilcare Global Clinical Supplies serves the Americas, Europe, and Asia with clinical trial materials support, services, and complete project management. Its services for solid, semi-solid, liquid, DEA (CI-V), and biotech clinical trial materials (CTM) satisfy a broad range of requirements; from pre-formulation research and development, manufacturing, analytical services and clinical supplies packaging and labeling, to IVRS, QP services, controlled temperature (cold chain) CTM storage, worldwide distribution, and returns and destructions accountability.

Bilcare play a crucial role in enabling the authentication of medicines

http://www.freepressindex.com/battling-fake-medicines-companies-bilcare-plays-crucial-role-605691.html

Bilcare play a crucial role in enabling the authentication of medicines: Battling Fake medicines

Most of us generally take it for granted that the medicine we buy from the neighborhood chemist is genuine. For if it is not, the consequences can quickly spin out of control, even before anyone can guess what went wrong. But the uncomfortable truth is: as much as 20-25 per cent of all medicines sold in India could be counterfeit! While the precise figure varies from country to country, and from year to year, several studies have placed the proportion of fake medicines at about this level. While the nature of counterfeiting can vary: sometimes it is an insufficient quantity of medicine, or plain chalk; at other times, it’s a completely wrong medicine! But a lot of times, the manufacturing companies depend on the packaging design and reliability to differentiate the counterfeit product from the genuine. And this is where companies such as the Pune-based Bilcare Ltd play a crucial role. Bilcare’s showpiece technology is its nonClonableID, which enables products to be authenticated as they move through the supply chain to the end consumer, thus protecting brands and preventing misuse. It also provides a reliable means for effective track-n-trace and e-pedigree of products across the supply chain – from manufacturer to consumer. The nanotechnology-based system comprises a fingerprint that can be seamlessly integrated into any supply chain system. This is of critical importance because the Indian pharmaceutical market is extremely diversified; a typical medium-sized pharmaceutical manufacturer might have to deal with as many as 5,000 stockiest and distributors and perhaps 250,000 retail chemists all across the country! Clearly there is unlimited scope and opportunity for fake drugs to slip through the system. And this affects not just Indian companies but also MNC’s whose products are often cutting edge and expensive. “Bilcare’s strong research team has enabled us to expand the application of our nonClonableID technology to other sectors such as fmcg, electronic components, the auto industry and even the fashion industry,” says Bilcare founder chairman, Mohan Bhandari.

Avoiding mistakes

In addition, the company has built a variety of tiny features into the packaging materials that it offers to its pharmaceutical customers. One of them, for example, is to micro-print the manufacturer’s name in minute, barely visible, size in the form of a ring on the aluminum foil of a tablet. This enables the drug manufacturer’s audit teams to quickly identify the fake products at the distributor or even retail chemist level! Another is to create images of droplets of varying sizes and shapes on the aluminum foil, or to incorporate a change of color into the packaging material. These technologies also help to avoid mistakes by the patient or the chemist, particularly when the doctor’s prescription is misplaced, discolored or damaged in some form or other. An interesting service that the company offers its customers is known as Bilcare Optima, which helps major pharmaceuticals select the form and quality of packaging materials that would be best suited for their products. Before this was introduced, it was often seen that medicinal formulations such as tablets, capsules, etc, would either degenerate in extreme conditions because of improper packaging or the packaging cost would escalate beyond acceptable limits. Besides, if the problems were discovered after the product was submitted to the us FDA or European regulators, the entire process of documentation and filing

would have to be repeated! The expenses involved in this entire procedure would completely upset the commercial calculations of manufacturer. These product offerings, along with a range of child resistant packaging and materials that can survive wide variations of climate and temperature, have made it possible for Bilcare to attract more than 2,500 companies in over 50 countries all over the world. Over the past decade or two, they have also transformed Bilcare into a global brand. Just last month, Bilcare: was recognized as one of the Admired 100 Brands & Leaders of Asia-2014-15 by WVP World Brands for which leading management consultancy firm Ernst & Young served as process advisor. Admired 100 Asia was launched under The Asian Brand Conclave in New Delhi. The conclave was attended by luminaries of marketing, advertising, corporate leaders from different industries and backgrounds, CEO’s, Asian entrepreneurs, VIP’s and other dignitaries. Admired 100 Asia is a research based listing of 100 brands across different categories. An industry research across a total of 25 categories in Asia was conducted on an initial list of 2,000 brands and shortlisted to 100.

Reference: Business India, Magazine of the Corporate World

Bilcare has been recognized as Admired 100 Brands & Leaders of Asia-2014-15 by VWP World Brands.

Ernst and Young is the process advisor to the independent jury led selection of the 100 chosen companies that won the recognition.

Admired 100 Asia was launched under The Asian Brand Conclave in New Delhi. The conclave was attended by luminaries of marketing, advertising, corporate leaders from different industries and

backgrounds, CEO’s, Asian entrepreneurs, VIP’s and other dignitaries.

Admired 100 Asia is a research-based listing on 100 brands across different categories. An industry research across a total of 25 categories in Asia was conducted on an initial list of 2,000 brands and shortlisted to 100.

Admired 100 Asia features the journey of brands and leaders from the Asian continent involving the regions of South East Asia, GCC Nations and the Indian Sub-Continent. It details a total of 100 Admired brands across various categories.  Admired 100 Asia is a research based listing of these selected brands and leaders from different countries of Asian continent, it bolsters a brand’s position, and value adds prominence and sets the brand apart from its competitors.

Admired 100 Asia was launched under The Asian Brand Conclave in New Delhi. The conclave was attended by luminaries of marketing, advertising, corporate leaders from different industries and backgrounds, CEO’s, Asian entrepreneurs, VIP’s and other dignitaries.

Admired 100 Asia, an initiative of VWP World Brands, research by White Page International, is world’s largest multi format platform of branding. It is an international independent platform on branding that recognizes and pays tribute by rewarding and reinforcing the remarkable stories of the admired brands & leaders from Asia, which has been captured in form of acoffee   table book, a dedicated portal, and feature on one of the leading business channels in India.